The Impact of HMO Development on Mental Health and Chemical Dependency Services
Abstract
The effects of the development of HMOs on the delivery of mental health and chemical dependency treatment services in Minneapolis-St. Paul were examined through structured interviews with representatives of HMOs and other provider groups. The structure and policies of five competing HMOs are described. Although all five HMOs have reduced their members' use of inpatient mental health and chemical dependency services, use of services by the non-HMO population remains substantially higher than national averages. HMO growth has stimulated the emergence of new types of mental health and chemical dependency treatment organizations to provide services to HMOs and has increased acceptance of goal-oriented, outpatient-based treatment strategies by providers.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
